Virtual Event
Target Biology and Modality Selection Strategies in Prostate Cancer Therapeutics
August 18 @ 10:00 am - 11:00 am
Virtual Event
Join this webinar to explore how target biology, tumor heterogeneity, and lineage evolution influence target and modality selection, with insights from representative targets including PSMA, B7-H3, STEAP1, KLK2, and DLL3.
Key Highlights:
- Understand the role of target biology in prostate cancer drug development.
- Explore how tumor heterogeneity and lineage evolution impact target selection.
- Learn how target characteristics guide modality selection, including ADCs and T-cell engagers (TCEs).
- Review the latest development strategies for emerging targets such as PSMA, B7-H3, STEAP1, KLK2, and DLL3.
Hosted by:
